Zenobia Therapeutics Inc.

A Leader in FBLD and CNS Disease
505 Coast Blvd, La Jolla, CA 92037

Zenobia Therapeutics was founded in 2008 with a focus on discovering treatments for neurodegenerative diseases using fragment-based lead discovery.

In 2014, Zenobia added a products division, Zenobia Fragments that supplies products and services to support fragment-based lead discovery. Our products are used in our internal CNS discovery research programs and have yielded hits for a diverse array of targets around the world. We also offer a collection of support services to compliment our products.